MedTrace Logo

Health Literacy in People With Chronic Obstructive Pulmonary Disease

NCT03216603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2021-12-14

No results posted yet for this study

Summary

Health literacy refers to personal and relational factors affecting a person's ability to acquire, understand and use information about health and health services. In a need assessment study it was found that, the health services need to focus on health literacy factors in the follow up of patients with chronic obstructive pulmonary disease (COPD).

Thus, this project evaluate the effect a of a health literacy partnership health promotion intervention (hospital, municipalities, university) after discharge from hospital with the use of motivational interviewing and tailored follow-ups on re-admission, health literacy, self-management quality of life and cost in people with COPD compared with usual care.

Conditions

Interventions

BEHAVIORAL

Health literacy intervention group

In the health literacy intervention group all patients will receive self-management help using a motivating interviewing (MI) technique delivered by two MI and COPD trained nurses once a week for eight weeks after hospitalization. Subsequently, the contact between the patients and the nurses will be by follow up motivational telephone calls once a month or more if needed for four months (i.a a total of six months intervention period).

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • Norwegian Extra Foundation for Health and Rehabilitation

    collaborator OTHER

  • Lovisenberg Diakonale Hospital

    lead OTHER

Principal Investigators

  • Christine Borge, Phd · University of Oslo and Lovisenberg Diaconal Hospital

  • Astrid K. Wahl, Phd · University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03216603 on ClinicalTrials.gov